FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/14/2023
Back to search
Official data from USPTO
CYTED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
08/14/2023
Trademark type
Combined
Nice classes
9, 10, 42, 44
Filing date
03/22/2021
Registration date
04/04/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/04/2023
Last transaction
04/04/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
GB
Examiner
BLAZICH, JOAN MICHELE
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a cuboctahedron shape and the word "CYTED".
Holders and representatives
Holders
Cyted Ltd
Representatives
Michael R. Friscia McCarter & English, LLP
Technical classification
Nice Classes
Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software for cancer and gastrointestinal disease screening and diagnostic purposes for use in medical decision support systems
Class 10
Diagnostic imaging apparatus for medical use; diagnostic testing apparatus for use in medical immunoassay procedures; diagnostic testing apparatus for use in medical molecular analyses; diagnosticexaminationmonitoring equipment for medical use and pathologyfor cancer and gastrointestinal disease; diagnostic instruments for medical use for pathology for detecting cancer and gastrointestinal disease; diagnostic measuring apparatus for medical use and pathologyfor cancer and gastrointestinal disease; medical diagnostic apparatus for medical purposes and pathologyfor cancer and gastrointestinal disease; medical diagnostic instruments for medical use for pathologyfor cancer and gastrointestinal disease
Class 42
Medical laboratories; medical and pharmacological research services; medical laboratory services; medical research; medical research laboratory services; medical research services; software as a service (SaaS) services featuring software for identifying markers for screening and diagnostic purposes for cancer and gastrointestinal disease; software creation; software customisation services; software design; software design and development; biomedical research services; design and development of medical technology; design and development of computer software for use with medical technology; platforms for artificial intelligence as software as a service (SaaS)software as a service (SaaS) services featuring software for identifying markers for screening and diagnostic purposes for cancer and gastrointestinal disease; database design and development; design and development of computer database programs and software; design and development of computer software for use with medical technologylogisticsreading datasupply chain management; design and development of computer software architecture; design and development of data display entry and output systemsdata processing apparatusprogrammessoftware and systems; design and development of diagnostic apparatus
Class 44
Medical services; medical testingscreening and diagnostic services for cancer and gastrointestinal disease; medical diagnostic testingmonitoring and reporting services; medical testing for diagnostic or treatment purposes; medical testing services relating to the diagnosis and treatment of disease; medical advisory services; medical treatment servicesfor pathology; arranging of medical treatmentproviding medical diagnostic testingmonitoring and reporting services for pathology in the field of cancer and gastrointestinal disease; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; performing diagnosis of diseases; medical services for the diagnosis of conditions of the human body; medical analysis services for cancer and gastrointestinal diseasescreening and diagnostics; medical examination of individuals; medical and healthcare clinics being facilities with access for patients; providing medical information regarding testing and diagnosis of diseases and infections; providing medical information regarding diagnosis and treatment of diseases and infections; medical analysis services for cancer diagnosis and prognosis; medical analysis services relating to the treatment of patients and persons; medical analysis servicesfor screening and diagnostic purposes provided by medical laboratories; medical laboratory services for the analysis of samples taken from patients; medical services relating to the removaltreatment and processing of human cells; computer aided medical diagnostic testing services
Publications
History of USPTO decisions and trademark events.
38 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/23/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/20/2023
FIMP
FINAL DISPOSITION PROCESSED
07/20/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/04/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/21/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/04/2023
GPNX
NOTIFICATION PROCESSED BY IB
01/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/17/2023
PUBO
PUBLISHED FOR OPPOSITION
01/17/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/04/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/28/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2022
ATRV
ATTORNEY REVIEW COMPLETED
12/12/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/27/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/23/2022
EXPI
EX PARTE APPEAL-INSTITUTED
11/23/2022
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
11/23/2022
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
11/23/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/09/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/09/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/06/2022
GNFR
FINAL REFUSAL E-MAILED
06/06/2022
CNFR
FINAL REFUSAL WRITTEN
06/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/31/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/31/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/31/2022
RFNT
REFUSAL PROCESSED BY IB
12/19/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/29/2021
RFRR
REFUSAL PROCESSED BY MPU
11/29/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/28/2021
CNRT
NON-FINAL ACTION WRITTEN
10/27/2021
DOCK
ASSIGNED TO EXAMINER
10/26/2021
MAFR
APPLICATION FILING RECEIPT MAILED
06/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/07/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/03/2021
Continuous trademark protection
Get notified about every new filing that threatens CYTED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.